A Systematic Review of Prognostic Factors in Patients with Cancer Receiving Palliative Radiotherapy: Evidence-Based Recommendations

Author:

Tam Alexander1,Scarpi Emanuela2ORCID,Maltoni Marco Cesare3,Rossi Romina4,Fairchild Alysa5,Dennis Kristopher6,Vaska Marcus7ORCID,Kerba Marc1

Affiliation:

1. Cumming School of Medicine, Department of Radiation Oncology, University of Calgary, Calgary, AB T2N 1N4, Canada

2. Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, 47014 Meldola, Italy

3. Medical Oncology Unit, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy

4. Palliative Care Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, 47014 Meldola, Italy

5. Department of Radiation Oncology, Cross Cancer Institute, Faculty of Medicine, University of Alberta, Edmonton, AB T6G 2R3, Canada

6. Division of Radiation Oncology, The Ottawa Hospital and the University of Ottawa, Ottawa, ON K1H 8L6, Canada

7. Knowledge Resource Service, Tom Baker Cancer Centre, Alberta Health Services, Calgary, AB T2N 4N2, Canada

Abstract

(1) Background: Prognostication in patients with cancer receiving palliative radiotherapy remains a challenge. To improve the process, we aim to identify prognostic factors in this population from the literature and offer evidence-based recommendations on prognostication in patients undergoing palliative radiotherapy for non-curable or advanced cancers. (2) Methods: A systematic review was performed on the medical literature from 2005 to 2023 to extract papers on the prognosis of palliative radiotherapy patients with advanced cancer. The initial selection was performed by at least two authors to determine study relevance to the target area. Studies were then classified based on type and evidence quality to determine final recommendations. (3) Results: The literature search returned 57 papers to be evaluated. Clinical and biological prognostic factors were identified from these papers to improve clinical decision making or construct prognostic models. Twenty prognostic models were identified for clinical use. There is moderate evidence supporting (i) evidence-based factors (patient, clinical, disease, and lab) in guiding decision making around palliative radiation; (ii) that certain biological factors are of importance; (iii) prognostication models in patients with advanced cancer; and that (iv) SBRT or re-irradiation use can be guided by predictions of survival by prognostic scores or clinicians. Patients with more favorable prognoses are generally better suited to SBRT or re-irradiation, and the use of prognostic models can aid in this decision making. (4) Conclusions: This evaluation has identified several factors or tools to aid in prognosis and clinical decision making. Future studies should aim to further validate these tools and factors in a clinical setting, including the leveraging of electronic medical records for data availability. To increase our understanding of how causal factors interact with palliative radiotherapy, future studies should also examine and include prediction of response to radiation as an outcome.

Publisher

MDPI AG

Reference47 articles.

1. Prognostication in advanced cancer: Update and directions for future research;Hui;Support. Care Cancer,2019

2. Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline;Stone;ESMO Open,2023

3. Prognostic factors in advanced cancer patients: Evidence-based clinical recommendations—A study by the Steering Committee of the European Association for Palliative Care;Maltoni;J. Clin. Oncol.,2005

4. Oxford Centre for Evidence-Based Medicine (2024, February 23). Levels of Evidence. Available online: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009.

5. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations;Guyatt;BMJ,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3